111 related articles for article (PubMed ID: 6323519)
1. Differences in the ratio of bioactive to immunoreactive serum luteinizing hormone during vasomotor flushes and hormonal therapy in postmenopausal women.
Chang SP; Shoupe D; Kletzky OA; Lobo RA
J Clin Endocrinol Metab; 1984 May; 58(5):925-9. PubMed ID: 6323519
[TBL] [Abstract][Full Text] [Related]
2. Elevated bioactive luteinizing hormone in women with the polycystic ovary syndrome.
Lobo RA; Kletzky OA; Campeau JD; diZerega GS
Fertil Steril; 1983 May; 39(5):674-8. PubMed ID: 6220924
[TBL] [Abstract][Full Text] [Related]
3. Effects of luteinizing hormone releasing hormone (LHRH) upon bioactive and immunoreactive serum LH levels in normal subjects.
Dufau ML; Beitins IZ; McArthur JW; Catt KJ
J Clin Endocrinol Metab; 1976 Sep; 43(3):658-67. PubMed ID: 783183
[TBL] [Abstract][Full Text] [Related]
4. Dose-related changes in LH bioactivity with intranasal GnRH agonist administration.
Chiang RS; Barnes RB; Shoupe D; Lobo RA
Contraception; 1985 Oct; 32(4):347-57. PubMed ID: 2934222
[TBL] [Abstract][Full Text] [Related]
5. Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study.
Chandeying V; Sangthawan M
J Med Assoc Thai; 2007 Sep; 90(9):1720-6. PubMed ID: 17957910
[TBL] [Abstract][Full Text] [Related]
6. Differing responses of plasma bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone to gonadotropin-releasing hormone antagonist and agonist treatments in postmenopausal women.
Matikainen T; Ding YQ; Vergara M; Huhtaniemi I; Couzinet B; Schaison G
J Clin Endocrinol Metab; 1992 Sep; 75(3):820-5. PubMed ID: 1517372
[TBL] [Abstract][Full Text] [Related]
7. The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay.
Jaakkola T; Ding YQ; Kellokumpu-Lehtinen P; Valavaara R; Martikainen H; Tapanainen J; Rönnberg L; Huhtaniemi I
J Clin Endocrinol Metab; 1990 Jun; 70(6):1496-505. PubMed ID: 2140831
[TBL] [Abstract][Full Text] [Related]
8. The effects of estrogen and progestin on endogenous opioid activity in oophorectomized women.
Shoupe D; Montz FJ; Lobo RA
J Clin Endocrinol Metab; 1985 Jan; 60(1):178-83. PubMed ID: 2981084
[TBL] [Abstract][Full Text] [Related]
9. Objective evidence that placebo and oral medroxyprogesterone acetate therapy diminish menopausal vasomotor flushes.
Albrecht BH; Schiff I; Tulchinsky D; Ryan KJ
Am J Obstet Gynecol; 1981 Mar; 139(6):631-5. PubMed ID: 7211966
[TBL] [Abstract][Full Text] [Related]
10. Bioassay of circulating luteinizing hormone in the rhesus monkey: comparison with radioimmunoassay during physiological changes.
Dufau ML; Hodgen GD; Goodman AL; Catt KJ
Endocrinology; 1977 Jun; 100(6):1557-65. PubMed ID: 404130
[TBL] [Abstract][Full Text] [Related]
11. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix).
Andreyko JL; Monroe SE; Marshall LA; Fluker MR; Nerenberg CA; Jaffe RB
J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507
[TBL] [Abstract][Full Text] [Related]
12. Low serum bioactive luteinizing hormone in nonorganic male impotence: possible relationship with altered gonadotropin-releasing hormone pulsatility.
Fabbri A; Jannini EA; Ulisse S; Gnessi L; Moretti C; Frajese G; Isidori A
J Clin Endocrinol Metab; 1988 Nov; 67(5):867-75. PubMed ID: 3141450
[TBL] [Abstract][Full Text] [Related]
13. Effects of acute stimulation with gonadotropin releasing hormone (GnRH) on biologically active serum luteinizing hormone (LH) in elderly men.
Celani MF; Montanini V; Baraghini GF; Carani C; Marrama P
J Endocrinol Invest; 1984 Dec; 7(6):589-95. PubMed ID: 6397502
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
[TBL] [Abstract][Full Text] [Related]
15. Preferential release of bioactive luteinizing hormone in response to endogenous and low dose exogenous gonadotropin-releasing hormone pulses in man.
Veldhuis JD; Johnson ML; Dufau ML
J Clin Endocrinol Metab; 1987 Jun; 64(6):1275-82. PubMed ID: 3553222
[TBL] [Abstract][Full Text] [Related]
16. Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women.
Lobo RA; McCormick W; Singer F; Roy S
Obstet Gynecol; 1984 Jan; 63(1):1-5. PubMed ID: 6318170
[TBL] [Abstract][Full Text] [Related]
17. LRH-stimulated release of bioactive and immunoreactive LH in a patient with the XX male syndrome.
Grandi M; Borghi A; Vaccari F; Celani MF
Exp Clin Endocrinol; 1987 Apr; 89(2):229-32. PubMed ID: 3301372
[TBL] [Abstract][Full Text] [Related]
18. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
[TBL] [Abstract][Full Text] [Related]
19. Estrogen regulates the gonadotropin-releasing hormone-stimulated secretion of biologically active luteinizing hormone.
Urban RJ; Veldhuis JD; Dufau ML
J Clin Endocrinol Metab; 1991 Mar; 72(3):660-8. PubMed ID: 1997520
[TBL] [Abstract][Full Text] [Related]
20. The changing ratio of bioactive to immunoreactive luteinizing hormone (LH) through puberty principally reflects changing LH radioimmunoassay dose-response characteristics.
Burstein S; Schaff-Blass E; Blass J; Rosenfield RL
J Clin Endocrinol Metab; 1985 Sep; 61(3):508-13. PubMed ID: 3894406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
